These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 741271
1. [Estramustine phosphate in the treatment of stage D prostatic carcinoma]. van Wyk J. S Afr Med J; 1978 Oct 14; 54(16):638. PubMed ID: 741271 [No Abstract] [Full Text] [Related]
2. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)]. Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M. Actas Urol Esp; 1984 Oct 14; 8(5):399-402. PubMed ID: 6524487 [No Abstract] [Full Text] [Related]
3. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy. Catane R, Kaufman J, Mittelman A, Murphy GP. JAMA; 1977 Jun 06; 237(23):2471. PubMed ID: 576957 [No Abstract] [Full Text] [Related]
4. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate. Nickel CJ, Morales A. Can J Surg; 1983 Sep 06; 26(5):434-8. PubMed ID: 6351988 [Abstract] [Full Text] [Related]
9. A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. Murphy GP, Gibbons RP, Johnson DE, Loening SA, Prout GR, Schmidt JD, Bross DS, Chu TM, Gaeta JF, Saroff J, Scott WW. J Urol; 1977 Aug 06; 118(2):288-91. PubMed ID: 142845 [No Abstract] [Full Text] [Related]
10. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate. Wong AL, McGeorge A, Abel BJ. Clin Oncol; 1981 Jun 06; 7(2):163-5. PubMed ID: 7249439 [No Abstract] [Full Text] [Related]
13. Treatment of advanced carcinoma of the prostate with Estracyt. Nagel R, Kölln CP. Prog Clin Biol Res; 1976 Sep 06; 6():267-84. PubMed ID: 1023214 [No Abstract] [Full Text] [Related]
14. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate. Catane R, Mittelman A, Kaufman J, Murphy GP. N Y State J Med; 1976 Nov 06; 76(12):1978-81. PubMed ID: 1069190 [No Abstract] [Full Text] [Related]
15. New steroidal alkylating agents in advanced stage D carcinoma of the prostate. Mittelman A, Catane R, Murphy GP. Cancer Treat Rep; 1977 Nov 06; 61(2):307-10. PubMed ID: 872134 [Abstract] [Full Text] [Related]
16. [Estracyt treatment in prostatic neoplasms]. Sander S. Tidsskr Nor Laegeforen; 1976 Jan 10; 96(1):27-8. PubMed ID: 1257949 [No Abstract] [Full Text] [Related]
17. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma]. Burgos FJ, Maganto E, Jiménez M, Mayayo T, Allona A, Mateos A, Escudero A, Romero-Aguirre C. Actas Urol Esp; 1988 Jan 10; 12(6):500-6. PubMed ID: 3232555 [No Abstract] [Full Text] [Related]
18. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer. Benson RC, Cummings K. Prog Clin Biol Res; 1989 Jan 10; 303():177-86. PubMed ID: 2674984 [No Abstract] [Full Text] [Related]
19. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations. Nilsson T, JONSSON G. Cancer Chemother Rep; 1975 Jan 10; 59(1):229-32. PubMed ID: 1093671 [Abstract] [Full Text] [Related]